XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 6 - Per Share Amounts | 9 Months Ended
--- | ---
Sep. 30, 2024
Notes to Financial Statements |
Earnings Per Share [Text Block] | Note 6. Per Share Amounts Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding. The Company calculates diluted shares using the treasury stock method. Because the Company reported a loss for the three-month period ended September 30, 2024, the potentially dilutive effects of approximately 62,000 of the Company’s stock options and 33,000 of the Company’s unvested restricted stock awards were not considered for the reporting period. The computation for the nine-month period ended September 30, 2024 excluded approximately 4,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during the periods. The computation for the three and nine-month periods ended September 30, 2023 excluded approximately 118,000 and 91,000 of the Company’s stock options because the price of the options was higher than the average market price during the period. The weighted average common shares outstanding for basic earnings per share for the three and nine-month periods ended September 30, 2024 and 2023 included approximately 123,000 and 123,000, respectively, of the Company's restricted stock awards that are fully vested but are deferred for issuance. The following table sets forth the computation of basic and diluted earnings per share for the three and nine-month periods ended September 30, 2024 and 2023:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Net (loss) income attributable to American Shared Hospital Services |  | $ | (207,000 | ) |  | $ | 118,000 |  |  | $ | 3,514,000 |  |  | $ | 195,000 |
Weighted average common shares for basic (loss) earnings per share |  |  | 6,482,000 |  |  |  | 6,366,000 |  |  |  | 6,482,000 |  |  |  | 6,336,000 |
Dilutive effect of stock options and restricted stock awards |  |  | - |  |  |  | 66,000 |  |  |  | 38,000 |  |  |  | 70,000 |
Weighted average common shares for diluted (loss) earnings per share |  |  | 6,482,000 |  |  |  | 6,432,000 |  |  |  | 6,520,000 |  |  |  | 6,406,000 |
Basic (loss) earnings per share |  | $ | (0.03 | ) |  | $ | 0.02 |  |  | $ | 0.54 |  |  | $ | 0.03 |
Diluted (loss) earnings per share |  | $ | (0.03 | ) |  | $ | 0.02 |  |  | $ | 0.54 |  |  | $ | 0.03 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration